Monoclonal antibody-beta-lactamase conjugates for the activation of a cephalosporin mustard prodrug.
Cephalosporin mustard (CM) was designed as an anticancer prodrug that could be activated in a site-specific manner by monoclonal antibody-beta-lactamase conjugates targeted to antigens present on tumor cell surfaces. Purified beta-lactamases from Bacillus cereus (BC beta L) and Escherichia coli (EC beta L) catalyzed the release of phenylenediamine mustard (PDM) from CM through a fragmentation reaction which occurs after the beta-lactam ring of CM is hydrolyzed. The Km and Vmax values were 5.7 microM and 201 mumol/min per mg for BC beta L and 43 microM and 29 mumol/min per mg for EC beta L, respectively. Conjugates of BC beta L were prepared by combining the F(ab')2 fragments of the maleimide-substituted monoclonal antibodies L6 and 1F5 with thiolated BC beta L. The conjugates showed little loss in enzymatic activity and bound nearly as well as the unmodified F(ab')2 monoclonal antibodies to antigens expressed on the H2981 human lung adenocarcinoma cell line (L6 positive, 1F5 negative). PDM was approximately 50-fold more cytotoxic than CM to H2981 cells. Treatment of the cells with L6-BC beta L followed by CM resulted in a level of cytotoxic activity that was comparable to that of PDM. This was most likely due to activation of CM by conjugate that bound to cell-surface antigens, since pretreatment of H2981 cells with BC beta L or 1F5-BC beta L enhanced the activity of CM to a lesser extent. Thus, we have shown that CM is a prodrug, and that it can be activated with immunological specificity by a monoclonal antibody-beta-lactamase conjugate.
Svensson
H P
HP
Bristol-Myers Squibb Pharmaceutical Research Institute, Seattle, Washington 98121.
Kadow
J F
JF
Vrudhula
V M
VM
Wallace
P M
PM
Senter
P D
PD
D000911:Antibodies, Monoclonal / Q000737:chemistry* / Q000276:immunology; D000970:Antineoplastic Agents / Q000737:chemistry* / Q000378:metabolism; D001409:Bacillus cereus / Q000201:enzymology; D001711:Biotransformation; D002470:Cell Survival / Q000187:drug effects; D002511:Cephalosporins / Q000737:chemistry* / Q000378:metabolism; D002851:Chromatography, High Pressure Liquid; D004926:Escherichia coli / Q000201:enzymology; D006801:Humans; D009588:Nitrogen Mustard Compounds / Q000737:chemistry* / Q000378:metabolism / Q000494:pharmacology; D011355:Prodrugs / Q000737:chemistry* / Q000378:metabolism; D014407:Tumor Cells, Cultured; D001618:beta-Lactamases / Q000737:chemistry* / Q000378:metabolism
D000911:Antibodies, Monoclonal; D000970:Antineoplastic Agents; D002511:Cephalosporins; D009588:Nitrogen Mustard Compounds; D011355:Prodrugs; C076378:cephalosporin mustard; C038005:phenylenediamine mustard; D001618:beta-Lactamases